GWM
AMPH icon

Gupta Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Gupta Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.2M Hold
100,000
– – 0.28% 81
2015
Q4 		$1.42M Buy
100,000
+25,000
+33% +$330K 0.36% 61
2015
Q3 		$877K Buy
75,000
+25,000
+50% +$375K 0.21% 96
2015
Q2 		$879K Buy
50,000
+45,000
+900% +$701K 0.22% 98
2015
Q1 		$75K Buy
+5,000
New +$66.8K 0.02% 338

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Gupta Wealth Management's AMPH Position: Q1 2016 in Review

Gupta Wealth Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q1 2016 at 100,000 shares worth $1.2M. The position accounts for 0.28% of the portfolio, ranked #81.

Gupta Wealth Management first reported a position in AMPH in Q1 2015 and has held it in 5 quarters since. The position peaked at $1.42M in Q4 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q1 2016.

  • Gupta Wealth Management held 100,000 shares of Amphastar Pharmaceuticals worth $1.2M as of Q1 2016.
  • Gupta Wealth Management left its Amphastar Pharmaceuticals share count unchanged in Q1 2016.
  • Amphastar Pharmaceuticals made up 0.28% of Gupta Wealth Management's portfolio in Q1 2016, its #81 holding.
  • Gupta Wealth Management first reported a position in Amphastar Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Amphastar Pharmaceuticals position peaked at $1.42M in Q4 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.